Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Yonemura, Yutaka ^a   Canbay, Emel ^a   Ishibashi, Haruaki ^a  

^a Kishiwada Tokushukai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COLON RESECTION; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; FEMALE; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; INTESTINE RESECTION; INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERIOPERATIVE CHEMOTHERAPY; PERIOPERATIVE PERIOD; PERITONEUM METASTASIS; RECTOSIGMOIDECTOMY; SIGMOIDECTOMY; SURGICAL MORTALITY; ADJUVANT CHEMOTHERAPY; AGED; COLORECTAL TUMOR; DRUG THERAPY; INCIDENCE; JAPAN; METASTASIS; MIDDLE AGED; MORTALITY; PERITONEUM TUMOR; PROGNOSIS; RISK FACTOR; STATISTICS; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; DRUG THERAPY; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84877247466     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/978394     Document Type: Article

References (19)

1. Chu D. Z. J., Lang N. P., Thompson C., Osteen P. K., Westbrook K. C., Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989 63 2 364 367 2-s2.0-0024530870 (Pubitemid 19035034)
2. Jayne D. G., Fook S., Loi C., Seow-Choen F., Peritoneal carcinomatosis from colorectal cancer. British Journal of Surgery 2002 89 12 1545 1550 2-s2.0-18744400770 10.1046/j.1365-2168.2002.02274.x (Pubitemid 35404323)
3. Verwaal V. J., Van Ruth S., De Bree E., Van Slooten G. W., Van Tinteren H., Boot H., Zoetmulder F. A. N., Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology 2003 21 20 3737 3743 2-s2.0-0142087625 10.1200/JCO.2003.04.187 (Pubitemid 46606227)
4. Jaquet P. J., Sugarbaker P. H., Sugarbaker P. H., Clinical research methodologies in diagnosis ans staging of patients with peritoneal carcinomatosis. Peritoneal Carcinomatosis: Principles and Management 1996 Norwell, Mass, USA Kluwar Academic 359 374
5. Yonemura Y., Ernemr A., Ishibashi H., Atlas and Principles of Peritonectomy 2012 Oosaka, Japan NPO to Support Peritoneal Surface Malignancy Treatment
6. Sanoff H. K., Sargent D. J., Campbell M. E., Morton R. F., Fuchs C. S., Ramanathan R. K., Williamson S. K., Findlay B. P., Pitot H. C., Goldberg R. M., Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. Journal of Clinical Oncology 2008 26 35 5721 5727 2-s2.0-57449096129 10.1200/JCO.2008.17.7147
7. Franko J., Shi Q., Goldman C. D., Pockaj B. A., Nelson G. D., Goldberg R. M., Pitot H. C., Grothey A., Alberts S. R., Sargent D. J., Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841. Journal of Clinical Oncology 2012 30 3 263 267 10.1200/JCO.2011.37.1039
8. Glehen O., Kwiatkowski F., Sugarbaker P. H., Elias D., Levine E. A., De Simone M., Barone R., Yonemura Y., Cavaliere F., Quenet F., Gutman M., Tentes A. A. K., Lorimier G., Bernard J. L., Bereder J. M., Porcheron J., Gomez-Portilla A., Shen P., Deraco M., Rat P., Gilly F. N., Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multiinstitutional study. Journal of Clinical Oncology 2004 22 16 3284 3292 2-s2.0-4344619216 10.1200/JCO.2004.10.012 (Pubitemid 41103684)
9. Verwaal V. J., Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy. Cancer Journal 2009 15 3 212 215 2-s2.0-67651152693 10.1097/PPO.0b013e3181a58d7c
10. Gomes da Silva R., Sugarbaker P. H., Analysis of 10 prognostic factors in 70 patients having complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. Journal of the American College of Surgeons 2006 203 6 878 886 2-s2.0-33751000229 10.1016/j.jamcollsurg. 2006.08.024 (Pubitemid 44751569)
11. Elias D., Raynard B., Farkhondeh F., Goéré D., Rouquie D., Ciuchendea R., Pocard M., Ducreux M., Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery. Gastroenterologie Clinique et Biologique 2006 30 10 1200 1204 2-s2.0-33750587049 gcb-10-2006-30-10-0399-8320- 101019-200519793 (Pubitemid 44682573)
12. Elias D., Delperro J. R., Sideris L., Benhamou E., Pocard M., Baton O., Giovannini M., Lasser P., Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Annals of Surgical Oncology 2004 11 5 518 521 2-s2.0-3242761601 10.1245/ASO.2004.09.008 (Pubitemid 40486734)
13. Glehen O., Cotte E., Schreiber V., Sayag-Beaujard A. C., Vignal J., Gilly F. N., Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. British Journal of Surgery 2004 91 6 747 754 2-s2.0-2942514375 10.1002/bjs.4473 (Pubitemid 38746144)
14. Pilati P., Mocellin S., Rossi C. R., Foletto M., Campana L., Nitti D., Lise M., Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Annals of Surgical Oncology 2003 10 5 508 513 2-s2.0-0042285892 10.1245/ASO.2003.08.004 (Pubitemid 40486913)
15. Verwaal V. J., Van Tinteren H., Van Ruth S., Zoetmulder F. A. N., Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. British Journal of Surgery 2004 91 6 739 746 2-s2.0-2942572767 10.1002/bjs.4516 (Pubitemid 38746143)
16. Sugarbaker P. H., Successful management of microscopic residual disease in large bowel cancer. Cancer Chemotherapy and Pharmacology, Supplement 1999 43 S15 S25 2-s2.0-0033021563 (Pubitemid 29244628)
17. Yan T. D., Morris D. L., CYtoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Annals of Surgery 2008 248 5 829 835 2-s2.0-56149089109 10.1097/SLA.0b013e31818a15b5
18. Esquivel J., Elias D., Baratti D., Kusamura S., Deraco M., Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. Journal of Surgical Oncology 2008 98 4 263 267 2-s2.0-50849099547 10.1002/jso.21053
19. Yonemura Y., Effects of neoadjuvant intraperitoneal/systemic chemotherapy (Bidirectional Chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer. International Journal of Surgical Oncology 2012 2012 8 148420 10.1155/2012/148420